Opus Genetics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-25.3M | $-9.3M | $-14.4M | $-18.5M | $-9.5M | $-6.2M | $-11.3M | $-14.0M |
| Depreciation & Amortization | $42.4K | $32.9K | $27.5K | $28.3K | $37.1K | $42.4K | $45.1K | $50.7K |
| Depreciation | — | — | — | $28.3K | $37.1K | $42.4K | $45.1K | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.0M | $1.4M | $1.0M | $608.8K | $565.4K | $231.0K | $638.6K | $584.7K |
| Net Cash from Operating Activities | $-15.4M | $-13.2M | $-17.4M | $-11.0M | $-8.0M | $-6.6M | $-15.5M | $-7.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-9.4M | — | — | — | $845.5K | $2.2M | $-545.9K | $-660.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | $0 | $0 |
| Net Cash from Financing Activities | $22.1M | — | — | — | $12.3M | $8.1M | $13.6M | $12.7M |
| Net Change in Cash | $-2.7M | $1.4M | $373.2K | $-8.9M | $5.2M | $3.6M | $-2.5M | $5.0M |
| Free Cash Flow | — | — | — | — | — | — | — | — |